Results 11 to 20 of about 399,381 (358)

Human Immunodeficiency Virus (HIV) [PDF]

Transfusion Medicine and Hemotherapy, 2016
With the introduction of combination antiretroviral therapy (cART), people living with human immunodeficiency virus (HIV) have achieved tremendous gains in life expectancy. Persons with perinatal HIV infection now commonly live into adulthood but have comorbidities associated with pediatric HIV infection and acquired immunodeficiency syndrome (AIDS ...
Angela Hall, Chris Scott, Matthew Buckland   +2 more
  +6 more sources

Human Immunodeficiency Virus (HIV) [PDF]

Transfusion Medicine and Hemotherapy, 2004
5 Assessment According to current knowledge, HIV-1 has been transmitted via blood and blood products in Germany since 1979. With the introduction of antibody testing of blood and plasma donations in 1985, transmission of infections via blood, blood components and plasma products has been dramatically reduced.
Reinhold E. Schmidt, Rita Crinelli, Aimee E. Pugh-Bernard, Aurora Cerasi, Antonella Antonelli, Sonja Serafini, Mauro Magnani, Michael Kohler, U.T. Seyfert, Giuditta Fiorella Schiavano, Amedeo J. Cappione, Alessandra Fraternale, Varsha Kumar, H. Kiesewetter, Syed Raza Ali, Gerhard Pindur, Peter Hellstern, Iñaki Sanz, Julia Skokowa, Jennifer H. Anolik, Laura Chiarantini, L. Rossi, J.E. Gessner   +22 more
openaire   +4 more sources

Immunity to Human Immunodeficiency Virus (HIV) Infection [PDF]

Clinical and Developmental Immunology, 2012
The advent of highly active antiretroviral therapy (HAART) in 1996 revolutionized life expectancy and quality of life of people infected by HIV in the developed Countries. Nowadays, HIV-infected patients can positively think that their life expectancy is comparable to that of people of the same age and with the same pattern of risk factors Indeed ...
Torti, C, Paiardini, M, GORI, ANDREA
openaire   +7 more sources

The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus [PDF]

, 1999
Infection with feline immunodeficiency virus (FIV) leads to the development of a disease state similar to AIDS in man. Recent studies have identified the chemokine receptor CXCR4 as the major receptor for cell culture-adapted strains of FIV, suggesting ...
Ackley C. D., Amara A., Barr M. C., Bleul C. C., Boyer V., Brelot A., Brian J. Willett,, Brown E. W., Brunner D., Cao J., Choe H., de Jong J. J., Dean G. A., Donzella G. A., Doranz B. J., Dow S. W., Dubay J. W., Egberink H. F., Endo Y., Endres M. J., Feng Y., Hesselgesser J., Hill C. M., Ho D. D., Hosie M. J., Ikeda Y., Langley R. J., Lu Z. H., Margaret J. Hosie, Muster T., Norimine J., Novotney C., Oberlin E., Olmsted R. A., Pancino G., Parolin C., Poeschla E. M., Reeves J. D., Reeves J. D., Robinson W. E., Siebelink K. H. J., Speck R. F., Talbott R. L., Vahlenkamp T. W., Verschoor E. J., Wild C., Willett B. J., Willett B. J., Willett B. J., Willett B. J., Wu L.   +50 more
core   +1 more source

The comparative value of feline virology research: can findings from the feline lentiviral vaccine be translated to humans? [PDF]

, 2017
Feline immunodeficiency virus (FIV) is a lentivirus of domestic cats that shares several similarities with its human counterpart, human immunodeficiency virus (HIV).
Beczkowski, Paweł M., Harris, Matthes, Hosie, Margaret J., Logan, Nicola, Techakriengkrai, Navapon, Willett, Brian   +5 more
core   +1 more source

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120 [PDF]

, 2001
BACKGROUND: Cellulose acetate phthalate (CAP), a pharmaceutical excipient used for enteric film coating of capsules and tablets, was shown to inhibit infection by the human immunodeficiency virus type 1 (HIV-1) and several herpesviruses. CAP formulations
A Boyum, A Robert Neurath, A Trkola, A Trkola, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, AR Neurath, Asim K Debnath, CD Rizzuto, CK Lapham, CM Javan, DR Burton, DR Littman, EA Berger, F Cocchi, G Alkhatib, H Choe, H Deng, J Bilello, JA Este, JC Lee, K Javaherian, KH Manson, L Wu, L Xiao, M Baba, M Baba, M Moulard, M Thali, MA Skinner, MC Peitsch, Nathan Strick, P Greenhead, PD Kwong, RA Anderson, RA Maguire, RF Speck, RJ Shattock, S Harada, S Laal, S Matsushita, S Rusconi, S Shaunak, T Dragic, T Gyotoku, T Kawamura, T Muster, TN Hart, WR Melander, Y Feng, YI Rumyantseva, Yun-Yao Li   +55 more
core   +3 more sources

Epidemiological and clinical aspects of HIV associated dementia at the University Hospital of Point G

Revue Malienne d’Infectiologie et de Microbiologie, 2017
Introduction Dementia is a real fact in the course of Human Immunodeficiency Virus infection. In Mali, no specific studies have been done to estimate its frequency.
Cheick Oumar Guinto, Toumany Coulibaly, S Berthé, Mamadou karembe, S Traoré, Thomas Coulibaly, Adama Sissoko, Guida Landoure, Sounkalo Dao, Moussa Traoré   +9 more
doaj   +1 more source

Peripartum infections and associated maternal mortality in rural Malawi [PDF]

, 2011
Article approval pendingTo assess associations between maternal mortality and severe morbidity and human immunodeficiency virus (HIV) infection, uptake of antiretroviral therapy, obstetric infections, and nonobstetric infections in a rural Malawian ...
Ahmad, Beatrice Mwagomba, Bemelmans, Bryant, Chiphangwi, Denny, Ford, Hogan, Jahn, Jos van Roosmalen, Lapaire, Louis, McIntyre, Mehta, Moodley, Mwagomba, Nathan Ford, Pollack, Semprini, Stefan de Vroome, Thomas van den Akker, van den Akker, Walson, Zachariah   +23 more
core   +3 more sources

Development of a human leukocyte antigen-based HIV vaccine [version 1; referees: 2 approved]

F1000Research, 2018
Human immunodeficiency virus (HIV) carries abundant human cell proteins, particularly human leukocyte antigen (HLA) molecules when the virus leaves host cells.
Yufei Wang
doaj   +1 more source

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India [PDF]

, 2011
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection.
Alvar, Bachani, Berman, Bern, Bora, Braitstein, C. Ferreyra, D. Remartinez, G. Mitra, Hurissa, Ikomi, J. van Griensven, K. Pandey, L. Flevaud, Lin, Lyons, M. Pece, Mathur, N. Kumar, N. Verma, P. Das, P. K. Sinha, P. Kumar, P. P. Palma, Pintado, R. Kumar, R. Mahajan, Redhu, Sinha, Sinha, Sundar, Sundar, ter Horst, Thakur, van Griensven   +34 more
core   +2 more sources